QA: Mirati Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2017_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 59,555,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 629,000
3 remainder_Assets 3,260,000
4 LiabilitiesCurrent 15,002,000
5 LiabilitiesNoncurrent 133,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,209,001
9 ResearchAndDevelopmentExpense 112,926,068
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 539,329
13 remainder_ComprehensiveNetIncome 12,390
  yvar yval
0 Assets 63,444,000
1 Liabilities 15,135,000
2 Expenses 128,135,069
3 Revenues 0
4 StockholdersEquity 48,309,000
5 NetIncome -127,595,740
6 ComprehensiveNetIncome -127,589,545
7 BaseVar 103,632,894
8 EconomicCapitalRatiobeforeLimitedLiability -0.567
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time